Daniel Tobler1, Markus Schwerzmann2, Judith Bouchardy3, Reto Engel4, Dominik Stambach4, Christine Attenhofer Jost5, Kerstin Wustmann2, Fabienne Schwitz2, Tobias Rutz6, Harald Gabriel7, Hans Peter Kuen8, Christoph Auf der Maur8, Angela Oxenius9, Theresa Seeliger9, Bruno Santos Lopes9, Francesca Bonassin9, Matthias Greutmann9. 1. Department of Cardiology, University Hospital Basel, University of Basel, Switzerland. 2. University Clinic of Cardiology, Centre for Congenital Heart Disease, Inselspital, University Hospital Bern, Switzerland. 3. Department of Cardiology and Cardiac Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, and Division of Cardiology, Hôpitaux Universitaires de Genève (HUG), Geneva, Switzerland. 4. Cardiology, Kantonsspital St. Gallen, Switzerlana. 5. Klinik im Park, Zurich, Switzerland; University Heart Centre, Department of Cardiology, University of Zurich, Switzerland. 6. Department of Cardiology and Cardiac Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. 7. Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Austria. 8. Centre for Congenital Heart Disease, Paediatric and Adult Cardiology, Luzerner Kantonsspital, Lucerne, Switzerland. 9. University Heart Centre, Department of Cardiology, University of Zurich, Switzerland.
Abstract
BACKGROUND: In 2013, a prospective registry for adults with congenital heart disease (CHD) was established in Switzerland, providing detailed data on disease characteristics and outcomes: Swiss Adult Congenital HEart disease Registry (SACHER). Its aim is to improve the knowledge base of outcomes in adults with CHD. The registry design and baseline patient characteristics are reported. METHODS: All patients with structural congenital heart defects or hereditary aortopathies, followed-up at dedicated adult CHD clinics, are asked to participate in SACHER. Data of participants are pseudonymised and collected in an electronic, web-based, database (secuTrial®). Collected data include detailed diagnosis, type of repair procedures, previous complications and adverse outcomes during follow-up. RESULTS: From May 2014 to December 2016, 2836 patients (54% male, mean age 34 ± 14 years), with a wide variety of congenital heart lesions, have been enrolled into SACHER. Most prevalent were valve lesions (25%), followed by shunt lesions (22%), cyanotic and other complex congenital heart disease (16%), diseases affecting the right heart, i.e., tetralogy of Fallot or Ebstein anomaly (15%), and diseases of the left ventricular outflow tract (13%); 337 patients (12%) had concomitant congenital syndromes. The majority had undergone previous repair procedures (71%), 47% of those had one or more reinterventions. CONCLUSION: SACHER collects multicentre data on adults with CHD. Its structure enables prospective data analysis to assess detailed, lesion-specific outcomes with the aim to finally improve long-term outcomes.
BACKGROUND: In 2013, a prospective registry for adults with congenital heart disease (CHD) was established in Switzerland, providing detailed data on disease characteristics and outcomes: Swiss Adult Congenital HEart disease Registry (SACHER). Its aim is to improve the knowledge base of outcomes in adults with CHD. The registry design and baseline patient characteristics are reported. METHODS: All patients with structural congenital heart defects or hereditary aortopathies, followed-up at dedicated adult CHD clinics, are asked to participate in SACHER. Data of participants are pseudonymised and collected in an electronic, web-based, database (secuTrial®). Collected data include detailed diagnosis, type of repair procedures, previous complications and adverse outcomes during follow-up. RESULTS: From May 2014 to December 2016, 2836 patients (54% male, mean age 34 ± 14 years), with a wide variety of congenital heart lesions, have been enrolled into SACHER. Most prevalent were valve lesions (25%), followed by shunt lesions (22%), cyanotic and other complex congenital heart disease (16%), diseases affecting the right heart, i.e., tetralogy of Fallot or Ebstein anomaly (15%), and diseases of the left ventricular outflow tract (13%); 337 patients (12%) had concomitant congenital syndromes. The majority had undergone previous repair procedures (71%), 47% of those had one or more reinterventions. CONCLUSION: SACHER collects multicentre data on adults with CHD. Its structure enables prospective data analysis to assess detailed, lesion-specific outcomes with the aim to finally improve long-term outcomes.
Authors: Francisco Javier Ruperti-Repilado; Daniel Tobler; Matthias Greutmann; Judith Bouchardy; Magalie Ladouceur; Laura Dos-Subira; Pastora Gallego; Harald Gabriel; Berto Bouma; Markus Schwerzmann Journal: Open Heart Date: 2021-04